Nuvo Group Ltd.
https://www.nuvocares.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nuvo Group Ltd.
Rare Diseases Rule, But Some Common Conditions Stand Out In Pending US Applications
Half of the FDA’s upcoming 2024 user fee goals target rare diseases, but highly prevalent conditions like uncomplicated urinary tract infections and atopic dermatitis are also up for agency action in the second half of the year.
Multiple China Biotech VC, PE Deals Kick Off A Strong Start To 2024
Jiangsu Vcare Pharmatech, Neurodawn Pharmaceutical and Shanghai Synvida Biotechnology stand out with funding rounds that each grossed roughly CNY200m ($28m) and above.
Top 10 Start-Up Spotlight Stories In 2020: Theradaptive’s ‘Bone Paint,’ BioIntelliSense’s BioButton, Heart Tech, Portable Ultrasound, Digital Health
A look back at Medtech Insight’s 10 most-read Start-Up Spotlight stories in 2020 pointed to diverse interest among our readers focusing on orthopedics, innovations in cardiac surgery, portable ultrasound tech and digital tools for tracking vital signs and monitoring patients at home.
Start-Up Spotlight: Nuvo Group’s Remote Monitoring Platform Could Make Prenatal Checks More Accessible
Israel-based Nuvo Group offers pregnant women prenatal checkups via its FDA-cleared remote monitoring platform.
Company Information
- Industry
-
Medical Devices
- Monitoring Equipment & Devices
-
Digital Health
- Artificial Intelligence
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice